Comparison of the epidemiology of invasive pneumococcal disease between Australia and New Zealand in 2017–2021: an observational study based on surveillance data

BACKGROUND: The Australian immunisation schedule uses 13-valent pneumococcal conjugate vaccine (PCV13), while New Zealand (NZ) changed from PCV13 to 10-valent PCV (PCV10) in 2017. In NZ, cases of serotype 19A (not in PCV10) have been increasing since 2017. We compared invasive pneumococcal disease (...

Descripción completa

Detalles Bibliográficos
Autores principales: Hagedoorn, Nienke N., Anglemyer, Andrew, Gilkison, Charlotte, Hartley, Mica, Walls, Tony
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10398586/
https://www.ncbi.nlm.nih.gov/pubmed/37547043
http://dx.doi.org/10.1016/j.lanwpc.2023.100764

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10398586/
https://www.ncbi.nlm.nih.gov/pubmed/37547043
http://dx.doi.org/10.1016/j.lanwpc.2023.100764

Ejemplares similares